|Application ||WB, IHC-P, IF, E|
|Dilution||IF (10 µg/ml), IHC-P (10 µg/ml),|
|Other Names||Krueppel-like factor 11, Transforming growth factor-beta-inducible early growth response protein 2, TGFB-inducible early growth response protein 2, TIEG-2, KLF11, FKLF, TIEG2|
|Reconstitution & Storage||Store at -20°C, avoid freeze thaw cycles.|
|Precautions||KLF11 Antibody (clone 10D8) is for research use only and not for use in diagnostic or therapeutic procedures.|
|Function||Transcription factor (PubMed:9748269, PubMed:10207080). Activates the epsilon- and gamma-globin gene promoters and, to a much lower degree, the beta-globin gene and represses promoters containing SP1-like binding inhibiting cell growth (PubMed:9748269, PubMed:10207080, PubMed:16131492). Represses transcription of SMAD7 which enhances TGF-beta signaling (By similarity). Induces apoptosis (By similarity).|
|Tissue Location||Ubiquitous. Higher expression in erythroid cells.|
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Transcription factor. Activates the epsilon- and gamma- globin gene promoters and, to a much lower degree, the beta-globin gene and represses promoters containing SP1-like binding inhibiting cell growth. Represses transcription of SMAD7 which enhances TGF-beta signaling. Induces apoptosis.
Cook T.,et al.J. Biol. Chem. 273:25929-25936(1998).
Asano H.,et al.Mol. Cell. Biol. 19:3571-3579(1999).
Scohy S.,et al.Genomics 70:93-101(2000).
Ota T.,et al.Nat. Genet. 36:40-45(2004).
Hillier L.W.,et al.Nature 434:724-731(2005).
If you have any additional inquiries please email technical services at email@example.com.